Direct links

Publications

  1. van Hulzen et al., 2017, ‘Genetic overlap between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence from GWAS meta-analysis’,Biological Psychiatry
  2. Mogavero et al., 2016, ‘Clock Genes, ADHD, and aggression’, Neurosci Biobehav Rev
  3. Chen et al., 2017, ‘Shared familial risk factors between attention-deficit/
    hyperactivity disorder and overweight/obesity – a population-based familial coaggregation study in Sweden’, Journal of Child Psychology and Psychiatry
  4. Rydell et al., 2017, ‘Genetic and environmental contributions to the association
    between ADHD and affective problems in early childhood—A Swedish population-based twin study’, Am J Med Genet.
  5. Ortega et al., 2017, ‘The Fat but Fit paradox: what we know and don’t know about it’, Br J Sports Med
  6. Landaas et al., 2016, ‘Vitamin levels in adults with ADHD’, BJPsych Open
  7. Yule et al., 2017, ‘Examining the association between attention deficit hyperactivity
    disorder and substance use disorders: A familial risk analysis’, Journal of Psychiatric Research
  8. von Rhein et al., 2017, ‘Network-Level Assessment of Reward-Related
    Activation in Patients with ADHD and Healthy Individuals’, Human Brain Mapping
  9. Garcia-Martínez et al., 2016, ‘Preliminary evidence for association of genetic variants
    in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder’, Transl Psychiatry
  10. Zayats et al., 2016, ‘Exome chip analyses in adult attention deficit hyperactivity disorder’, Transl Psychiatry
  11. Cabana-Domínguez et al., 2016, ‘A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence’, Sci Rep
  12. Merker et al., 2017, ‘SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder’, J Child Psychol Psychiatry
  13. Faraone et al., 2017, ‘The Familial Co-Aggregation of Attention-Deficit/Hyperactivity Disorder and Intellectual Disability: A Register-Based Family Study’, J Am Acad Child Adolesc Psychiatry
  14. Hoogman et al., 2017, ‘Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis’, Lancet Psychiatry
  15. Kurrikoff et al., 2018, ‘Association of the COMT Val108/158Met genotype with professional career and education: The Val-allele is more frequent in managers and in enterprising occupations’, Personality and Individual Differences
  16. Patak et al., 2017, ‘SLC9A9 Co-expression modules in autism-associated brain regions’, Autism Res
  17. Oldehinkel et al., 2016, ‘Functional connectivity in cortico-subcortical brain networks underlying reward processing in attention-deficit/hyperactivity disorder’, Neuroimage Clin
  18. Solberg et al., 2018, ‘Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder’, Acta Psychiatr Scand.
  19. Du Rietz et al., 2018, ‘Association of polygenic risk for attention-deficit / hyperactivity disorder with co-occuring traits and disorders’, Biol. Psych.
  20. Mayer et al., 2018, ‘Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial’, Trials.
  21. Du Rietz et al., 2018, ‘Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurringTraits and Disorders’, Biol Psychiatry Cogn Neurosci Neuroimaging.
  22. Pineda-Cirera et al., 2018, ‘Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample’, Drug Alcohol Depend.
  23. Cabana-Domínguez et al., 2018, ‘Association of the PLCB1 gene with drug dependence’, Sci Rep.
  24. Cabana-Domínguez et al., 2018, ‘MiR-9, miR-153 and miR-124 are downregulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence’, Transl Psychiatry. 
  25. Martin et al., 2018, ‘A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.’, Biol Psychiatry. 
  26. Demontis et al., 2019, ‘Discovery of the first genome-wide significant risk loci for ADHD’, Nature Genetics
  27. Chen et al., 2018, ‘Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study’, PLoS One.
  28. Chen et al., 2018, ‘Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden’, Psychol Med. 
  29. Solberg et al., 2018, ‘Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder’, Acta Psychiatr Scand.
  30. Corominas et al., 2018, ‘Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing’, Mol Psychiatry
  31. Ortega et al., 2018, ‘Role of Physical Activity and Fitness in the Characterization and Prognosis of the Metabolically Healthy Obesity Phenotype: a Systematic Review and Meta-Analysis’, Prog Cardiovasc Dis
  32. Ostergaard et al., 2017, ‘Teenage Parenthood and Birth Rates for Individuals With and Without Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study’, J Am Acad Child Adolesc Psychiatry
  33. Shadrin et al., 2018, ‘Novel Loci Associated With Attention-Deficit/Hyperactivity Disorder Are Revealed by Leveraging Polygenic Overlap With Educational Attainment’, J Am Acad Child Adolesc Psychiatry
  34. Faraone et al., 2018, ‘The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities’, Neurosci Biobehav Rev
  35. Zhang-James et al., 2018, ‘An integrated analysis of genes and functional pathways for aggression in human and rodent models’, Mol Psychiatry
  36. Faraone et al., 2018, ‘Genetics of attention deficit hyperactivity disorder’, Mol Psychiatry
  37. Fernandez-Castillo et al., 2017, ‘RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior’, Eur Neuropsychopharmacol
  38. Sullivan et al., 2018, ‘Psychiatric Genomics: An Update and an Agenda’, Am J Psychiatry 
  39. Franke et al., 2018, ‘Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan’, Eur Neuropsychopharmacol
  40. Meier et al., 2018, ‘Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood’, Br J Psychiatry
  41. Ottosen et al., 2019, ‘Sex Differences in Comorbidity Patterns of Attention-Deficit/Hyperactivity Disorder’, J Am Acad Child Adolesc Psychiatry
  42. Tokko et al., 2018, ‘Relapse of drunk driving and association with traffic accidents, alcohol-related problems, and biomarkers of impulsivity’, Acta Neuropsychiatr
  43. Migueles et al., 2018, ‘Comparability of published cut-points for the assessment of physical activity: Implications for data harmonization’, Scand J Med Sci Sports
  44. Grimm et al., 2018, ‘Recent developments in the genetics of attention-deficit hyperactivity disorder’, Psychiatry and Clinical Neurosciences
  45. Zhang-James et al., 2019, ‘Oral Methylphenidate Treatment of an Adolescent ADHD Rat Model Does Not Alter Cocaine-Conditioned Place Preference during Adulthood: A Negative Report’, J Psychiatr Brain Sci
  46. Libutzki et al., 2019, ‘Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis’, Eur Psychiatr
  47. Torrico et al., 2019, ‘Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes’, J Psychiatry Neurosci
  48. Cabana-Domínguez et al., 2019, ‘Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions’, Prog Neuropsychopharmacol Biol Psychiatry
  49. Arcos-Burgos et al., 2019, ‘ADGRL3 (LPHN3) variants predict substance use disorder’, Transl Psychiatr
  50. Hartman et al., 2019, ‘Stress Exposure and the Course of ADHD from Childhood to Young Adulthood: Comorbid Severe Emotion Dysregulation or Mood and Anxiety Problems’, Journal of Clinical Medicine
  51. Hegvik et al., 2019, ‘Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.’, Molecular Psychiatry
  52. Solberg et al., 2019, ‘Patterns of Psychiatric Comorbidity and Genetic
    Correlations Provide New Insights Into Differences Between Attention-Deficit / Hyperactivity Disorder and Autism Spectrum Disorder’, Biological Psychiatry
  53. Sánchez-Mora et al., 2019, Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells”, Neuropsychopharmacology
  54. Gohr-Mansson et al., 2019, The effects of practicing target-shooting sport on the severity of inattentive, hyperactive, and impulsive symptoms in children: a non-randomised controlled open-label study in Denmark, Nordic J Psychiatry.
  55. Sun et al., 2019, Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder, JAMA Psychiatry.
  56. Schullehner et al., 2019, Lithium in drinking water associated with adverse mental health effects, Schizophr Res.
  57. Fitzgerald et al., 2019, Suicidal behaviour among persons with attention-deficit hyperactivity disorder, Br J Psychiatry.
  58. Plana-Ripoll et al., 2019, Exploring Comorbidity Within Mental Disorders Among a Danish National Population, JAMA Psychiatry.
  59. Christensen et al., 2019, Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring, JAMA Netw Open.
  60. Demontis et al., 2019, Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder, Nat Genet
  61. Demontis et al., 2019, Genome-wide association study implicates CHRNA2 in cannabis use disorder, Nature Neuroscience
  62. Grimm O et al., 2019, Amisulpride and l‐DOPA modulate subcortical brain nuclei connectivity in resting‐state pharmacologic magnetic resonance imaging, Human Brain Mapping
  63. Harich B et al., 2019, From man to fly – convergent evidence links FBXO25 to ADHD and comorbid psychiatric phenotypes., J Child Psychol Psychiatry
  64. Klein et al., 2019, Genetic markers of ADHD-related variations in intracranial volume, Am J Psychiatry
  65. Hoogman et al., 2019, Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples, Am J Psychiatry
  66. Arias-Vásquez et al., 2019, A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms, Behav Genet.
  67. Li et al., 2019, ADHD Symptoms in the Adult General Population Are Associated With Factors Linked to ADHD in Adult Patients, Eur Neuropsychopharmacol.
  68. Faraone et al., 2019, Sleep-Associated Adverse Events During Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis, J Clin Psychiatr.
  69. Migueles et al., 2019, Comparability of accelerometer signal aggregation metrics across placements and dominant wrist cut points for the assessment of physical activity in adults, Scientific Reports.
  70. Muntaner-Mas et al., 2019, A Systematic Review of Fitness Apps and Their Potential Clinical and Sports Utility for Objective and Remote Assessment of Cardiorespiratory Fitness, Sport Medicine.
  71. Geuijen et al., 2019, Overweight in family members of probands with ADHD, ECAP.
  72. Luht et al., 2019, Efficiacy of intervention at traffic schools reducing impulsive action, and association with candidate gene variants, Acta Neuropsychiatrica.
  73. Joost et al., 2019, Association between Transcription Factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study, International Journal of Obesity.
  74. Sánchez-Mora et al., 2019, Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells, Neuropsychopharmacology.
  75. Soler Artigas et al., 2019, Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality, Mol Psychiatry.
  76. Brunkhorst-Kanaan et al., 2020, The Quantified Behavioral Test—A Confirmatory Test in the Diagnostic Process of Adult ADHD?, Frontiers in Psychiatry
  77. Li et al., 2020, Maternal pre-pregnancy overweight/obesity and the risk of attention-deficit/hyperactivity disorder in offspring: a systematic review, metaanalysis and quasi-experimental family-based study, International Journal of Epidemiology.
  78. Martin et al., 2020, Investigating gender-specific effects of familial risk for attention-deficit hyperactivity disorder and other neurodevelopmental disorders in the Swedish population, BJPsych Open.
  79. Andersson et al., 2020, Attention-deficit/hyperactivity disorder and smoking habits in pregnant women, Plos One.
  80. van Donkelaar et al., 2020, Monoamine and neuroendocrine gene-sets associate with frustration-based aggression in a gender-specific manner, Eur Neuropsychopharmacol.
  81. Wolfers et al., 2020, Individual Differences v. the Average Patient: Mapping the Heterogeneity in ADHD Using Normative Models, Psychol Med.
  82. Zhang-James et al., 2020, Machine-Learning Prediction of Comorbid Substance Use Disorders in ADHD Youth Using Swedish Registry Data, J Child Psychol Psychiatry.
  83. Esteller-Cucala et al., 2020, Genomic Analysis of the Natural History of Attention-Deficit/Hyperactivity Disorder Using Neanderthal and Ancient Homo Sapiens Samples, Scientific Reports.
  84. Torrico et al., 2020, Involvement of the 14-3-3 Gene Family in Autism Spectrum Disorder and Schizophrenia: Genetics, Transcriptomics and Functional Analyses, J Clin Med.
  85. Migueles et al., 2020, Step-Based Metrics and Overall Physical Activity in Children With Overweight or Obesity: Cross-Sectional Study, JMIR mHealth and uHealth.
  86. Zavala-Crichton et al., 2020, IAssociation of Sedentary Behavior With Brain Structure and Intelligence in Children With Overweight or Obesity: The ActiveBrains Project, Journal of Clinical Medicine.
  87. Migueles et al., 2020, Associations of Objectively-Assessed Physical Activity and Sedentary Time With Hippocampal Gray Matter Volume in Children With Overweight/Obesity, Journal of Clinical Medicine.
  88. Betari et al., 2020, Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis, Future Medicinal Chemistry.
  89. Roth-Mota et al., 2020, Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures, Neuropsychopharmacology
  90. Rovira et al., 2020, Shared genetic background between children and adults with attention deficit/hyperactivity disorder, Neuropsychopharmacology
  91. Rovira et al., 2020, Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults, Translational Psychiatry.
  92. Mayer J et al., 2021, Cognitive mechanisms underlying depressive disorders in ADHD: A systematic review.
  93. Schiweck et al., 2021, Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis.
  94. Brunkhorst-Kanaan N et al., 2021, ADHD and accidents over the life span – A systematic review.
  95. Grimm O et al., 2020, No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
  96. Grimm O et al., 2020, Impulsivity and Venturesomeness in an adult ADHD sample: relation to personality, comorbidity and polygenic risk.
  97. Grimm O et al., 2021, Transdiagnostic neuroimaging of reward system phenotypes in ADHD and comorbid disorders.
  98. du Rietz et al., 2021, Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study.
  99. Martin J et al., 2020, Investigating gender-specific effects of familial risk for attention-deficit hyperactivity disorder and other neurodevelopmental disorders in the Swedish population.
  100. Koch et al., 2021, Using e-diaries to investigate ADHD – State-of-the-art and the promising feature of just-in-time-adaptive interventions.
  101. Waddington F et al., 2020, A polygenic risk score analysis of ASD and ADHD across emotion recognition subtypes.
  102. Li T. et al., 2020, Mapping relationships between ADHD genetic liability, stressful life events, and ADHD symptoms in healthy individuals.
  103. Li T. et al., 2021, Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes.
  104. Brikell I. et al., 2021, Insights into attention-deficit/hyperactivity disorder from recent genetic studies.
  105. Martins-Silva T. et al., 2021, Obesity and ADHD: Exploring the role of body composition, BMI polygenic risk score, and reward system genes.
  106. Paraskevopoulou M. et al., 2020, Effects of substance misuse on reward-processing in patients with attention-deficit/hyperactivity disorder.
  107. Paraskevopoulou M. et al., 2020, Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
  108. Paraskevopoulou, M. et al., 2021, Effects of substance misuse on inhibitory control in patients with attention-deficit/hyperactivity disorder.
  109. Gido H Schoenmacker et al., 2020, Identification and validation of risk factors for antisocial behaviour involving police.
  110. Kuaikuai D. et al., 2021, Gray matter networks associated with attention and working memory deficit in ADHD across adolescence and adulthood.
  111. Qi Chen et al., 2020, Predicting suicide attempt/suicide following a visit to psychiatric specialty care by applying machine learning to the Swedish national registry data.
  112. Biederman J. et al., 2020, Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD.
  113. Biederman J. et al., 2021, Can polygenic risk scores help identify pediatric bipolar spectrum and related disorders?: A systematic review.
  114. Biederman J. et al., 2021, The child behavior checklist can aid in characterizing suspected comorbid psychopathology in clinically referred youth with ADHD.
  115. Chang S. et al., 2020, Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders.
  116. Faraone S. et al., 2020, The Impact of Attention-Deficit/Hyperactivity Disorder Medications on Suicidality: Implications and Mechanisms.
  117. Faraone S. et al., 2021, Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.
  118. Faraone S. et al., 2021, The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
  119. Hess J. et al., 2020, Autophagy, apoptosis, and neurodevelopmental genes might underlie selective brain region vulnerability in attention-deficit/hyperactivity disorder.
  120. Radonjić N. et al., 2021, Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders.
  121. Zhang-James Y. et al., 2020, Machine-Learning prediction of comorbid substance use disorders in ADHD youth using Swedish registry data.
  122. Zhang-James Y. et al., 2021, Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis.
  123. Muntaner-Mas A. et al., 2021, Low cardiorespiratory fitness and obesity for ADHD in childhood and adolescence: A 6-year cohort study .
  124. Migueles J. et al., 2021, GRANADA consensus on analytical approaches to assess associations with accelerometer-determined physical behaviours (physical activity, sedentary behaviour and sleep) in epidemiological studies.
  125. Muntaner-Mas A. et al., 2021, Smartphone App (2kmFIT-App) for Measuring Cardiorespiratory Fitness: Validity and Reliability Study
  126. Betari N. et al., 2020, Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
  127. Betari N. et al., 2020, Inhibition of tryptophan hydroxylases and monoamino oxidase-A by proton pump inhibitors – in vitro and in vivo investigations.
  128. Betari N. et al., 2021, Synthetic corticosteroids as tryptophan hydroxylase stabilizers.
  129. Solberg et al., 2020, Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder.
  130. Libutzki et al., 2020, Disease burden and direct medical costs of incident adult ADHD – A retrospective longitudinal analysis based on German statutory health insurance claims.
  131. Palm D. et al., 2021, Norepinephrine influences the circadian clock in human dermal fibroblasts from participants with a diagnosis of attention deficit hyperactivity disorder.
  132. Faltraco F. et al., 2021, Atomoxetine and circadian gene expression in human dermal fibroblasts from participants with a diagnosis of attention-deficit hyperactivity disorder.
  133. Faltraco F. et al., 2021, Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.
  134. Palm D. et al., 2021, Evolutionary conservations, changes of circadian rhythms and their effect on circadian disturbances and therapeutic approaches.
  135. Muntaner-Mas A. et al., 2021, Low cardiorespiratory fitness and obesity for ADHD in childhood and adolescnece: A 6-year cohort study.
  136. Katus U. et al., 2020, The role of reward sensitivity in obesity and its association with Transcription Factor AP-2B: A longitudinal birth cohort study.
  137. Pulver A. et al., 2020, Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender.
  138. Pulver A. et al., 2020, Reward sensitivity, affective neuroscience personality, symptoms of attention-deficit/hyperactivity disorder, and TPH2-703G/T (rs 4570625) genotype.
  139. Vaht M. et al., 2020, Variants of the Aggression-Related RBFOX1 Gene in a Population Representative Birth Cohort Study: Aggressiveness, Personality, and Alcohol Use Disorder.
  140. Katus U. et al., 2021, Neuropeptide Y gene variants in obesity, dietary intake, blood pressure, lipid and glucose metabolism: A longitudinal birth cohort study.
  141. Klaus K. et al., 2021, Interactive effects of DRD2 rs6277 polymorphism, environment and sex on impulsivity in a population-representative study.
  142. Rovira P. et al., 2020, Shared genetic background between attention-deficit/hyperactivity disorder in adults and children.
  143. Rovira P. et al., 2020, Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults.
  144. Vilar-Ribó L. et al., 2021, Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
  145. Pineda-Cirera L. et al., 2021, Exploring allele specific methylation in drug dependence susceptibility.
  146. Coleman J. et al., 2020, The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls.
  147. Vainieri I. et al., 2021, Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments.
  148. Arenas C. et al., 2021, New Distance-Based approach for Genome-Wide Association Studies.
  149. Cormand B, et al., 2021, Genomics and epigenomics of substance use disorders: An introduction.
  150. Pineda-Cirera L. et al., 2021, Exploring allele specific methylation in drug dependence susceptibility.
  151. Demontis D. et al., 2021, Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder.
  152. Yang Z. et al., 2021, Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum.
  153. Martin J. et al., 2021, Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits.
  154. Johnson E. et al., 2020, A large-scale genome-wide association study meta-analysis of cannabis use disorder.
  155. Patel Y. et al., 2021, Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders.

Disseminating results

© 2021 CoCA ADHD Comorbidity

Legal Disclaimer

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667302. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.